Abstract
Occult atrial fibrillation (AF) is a common cause of cryptogenic stroke. This study aimed to investigate the utility of surrogate markers within the clot (clot markers), in combination with serum biomarkers, to identify AF-associated clots in patients who underwent mechanical thrombectomy. Each retrieved thrombus was analyzed to identify fibrin, red blood cells, platelets — CD61 staining (PLT) and T-CD4 lymphocyte/macrophage/monocyte (CD4) profile. Serum biomarkers such as D-dimer, lipoprotein (A), and brain natriuretic peptide (BNP) were also assessed in the acute phase of the stroke. Patients with stroke-related AF and large artery atherosclerosis (LAA) stroke were compared by matched case-control design to identify markers associated with AF clot profile. The predictive abilities of clot markers and serum biomarkers to detect AF clot were tested in patients with cryptogenic stroke. In patients with AF clot, the PLT percentage was higher (66.64% vs. 55.43%, OR = 1.03); CD4 percentage was lower (3.84% vs. 7.95%, OR = 0.95); and BNP marker was higher (2114 pg/ml vs. 276 pg/ml, OR = 1.04) compared to LAA clot. PLT was independently associated to AF-clot (OR, 1.04) but demonstrated moderate ability to identify AF-clot cases (C-test 0.668, p = 0.018). The combination of PLT with BNP significantly improved AF-clot prediction (C-test 0.847, p < 0.001). The clot composition of patients with cryptogenic stroke and AF detection showed four-fold higher PLT and BNP pattern of risk than patients with cryptogenic stroke without AF detection (38.5% vs. 8.7%) (OR = 1.40). Integrating intra-thrombus platelet with serum BNP offers a promising approach for detecting AF-associated clots in patients with cryptogenic stroke.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12975-023-01220-x/MediaObjects/12975_2023_1220_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12975-023-01220-x/MediaObjects/12975_2023_1220_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12975-023-01220-x/MediaObjects/12975_2023_1220_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12975-023-01220-x/MediaObjects/12975_2023_1220_Fig4_HTML.png)
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available on request from the corresponding author.
References
Hart RG, Diener HC, Connolly SJ. Embolic strokes of undetermined source: support for a new clinical construct--authors’ reply. Lancet Neurol. 2014;13(10):967.
Ntaios G, Hart RG. Embolic stroke. Circulation. 2017;136(25):2403–5.
Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–31.
Gawaz M, Stellos K, Langer HF. Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. J Thromb Haemost. 2008;6(2):235–42.
Buxhofer-Ausch V, Steurer M, Sormann S, Schloegl E, Schimetta W, Gisslinger B, et al. Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia. Eur J Haematol. 2016;97(6):511–6.
Boeckh-Behrens T, Kleine JF, Zimmer C, Neff F, Scheipl F, Pelisek J, et al. Thrombus histology suggests cardioembolic cause in cryptogenic stroke. Stroke. 2016;47(7):1864–71.
Swystun LL, Liaw PC. The role of leukocytes in thrombosis. Blood. 2016;128(6):753–62.
Staessens S, De Meyer SF. Thrombus heterogeneity in ischemic stroke. Platelets. 2021;32(3):331–9.
Schuhmann MK, Gunreben I, Kleinschnitz C, Kraft P. Immunohistochemical analysis of cerebral thrombi retrieved by mechanical thrombectomy from patients with acute ischemic stroke. Int J Mol Sci. 2016;17(3):298.
Dargazanli C, Rigau V, Eker O, Riquelme Bareiro C, Machi P, Gascou G, et al. High CD3+ cells in intracranial thrombi represent a biomarker of atherothrombotic stroke. PLoS One. 2016;11(5):e0154945.
Blair P, Rex S, Vitseva O, Beaulieu L, Tanriverdi K, Chakrabarti S, et al. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res. 2009;104(3):346–54.
Grosse GM, Werlein C, Blume N, Abu-Fares O, Götz F, Gabriel MM, et al. Circulating cytokines and growth factors in acute cerebral large vessel occlusion-association with success of endovascular treatment. Thromb Haemost. 2022;122(4):623–32.
Ramos-Pachón A, López-Cancio E, Bustamante A, Pérez de la Ossa N, Millán M, Hernández-Pérez M, et al. D-Dimer as predictor of large vessel occlusion in acute ischemic stroke. Stroke. 2021;52(3):852–8.
Maruyama K, Shiga T, Iijima M, Moriya S, Mizuno S, Toi S, et al. Brain natriuretic peptide in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(5):967–72.
Cao R, Jiang Y, Li L, Lu Y, Wang J, Yu K, et al. BNP on admission combined with imaging markers of multimodal CT to predict the risk of cardioembolic stroke. Dis Markers. 2022;2022:3327967.
Pagola J, Juega J, Francisco-Pascual J, Bustamante A, Penalba A, Pala E, et al. Predicting atrial fibrillation with high risk of embolization with atrial strain and NT-proBNP. Transl Stroke Res. 2021;12(5):735–41.
Anderson A, Klein J, White B, Bourgeois M, Leonard A, Pacino A, et al. Training and certifying users of the National Institutes of Health Stroke Scale. Stroke. 2020;51(3):990–3.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–418.
Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41.
Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839–43.
Brinjikji W, Nogueira RG, Kvamme P, Layton KF, Delgado Almandoz JE, Hanel RA, et al. Association between clot composition and stroke origin in mechanical thrombectomy patients: analysis of the Stroke Thromboembolism Registry of Imaging and Pathology. J Neurointerv Surg. 2021;13(7):594–8.
Kitano T, Hori Y, Okazaki S, Shimada Y, Iwamoto T, Kanki H, et al. An older thrombus delays reperfusion after mechanical thrombectomy for ischemic stroke. Thromb Haemost. 2022;122(3):415–26.
García-Tornel Á, Rubiera M, Requena M, Muchada M, Pagola J, Rodriguez-Luna D, et al. Sudden recanalization: a game-changing factor in endovascular treatment of large vessel occlusion strokes. Stroke. 2020;51(4):1313–6.
Pagola J, Juega J, Francisco-Pascual J, Moya A, Sanchis M, Bustamante A, et al. Yield of atrial fibrillation detection with textile wearable holter from the acute phase of stroke: Pilot study of Crypto-AF registry. Int J Cardiol. 2018;251:45–50.
Lee S, Bartlett B, Dwivedi G. Adaptive immune responses in human atherosclerosis. Int J Mol Sci. 2020;21(23)
Dossena M, Ferrario A, Lopardo V, Ciaglia E, Puca AA. New Insights for BPIFB4 in Cardiovascular Therapy. Int J Mol Sci. 2020;21(19):7163.
Juega J, Palacio-Garcia C, Rodriguez M, Deck M, Rodriguez-Luna D, Requena M, et al. ITACAT study group. Monocyte-to-Lymphocyte Ratio in Clot Analysis as a Marker of Cardioembolic Stroke Etiology. Transl Stroke Res. 2022;13(6):949–958.
Sporns PB, Hanning U, Schwindt W, Velasco A, Minnerup J, Zoubi T, et al. Ischemic stroke: what does the histological composition tell us about the origin of the thrombus? Stroke. 2017;48(8):2206–10.
Fitzgerald S, Dai D, Wang S, Douglas A, Kadirvel R, Layton KF, et al. Platelet-rich emboli in cerebral large vessel occlusion are associated with a large artery atherosclerosis source. Stroke. 2019;50(7):1907–10.
Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350(7):655–63.
Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, et al. Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol. 2008;51(19):1874–82.
Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic M, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol. 2004;44(10):1988–95.
Takase H, Dohi Y, Sonoda H, Kimura G. Prediction of atrial fibrillation by B-type natriuretic peptide. J Atr Fibrillation. 2013;5(6):674.
Acknowledgements
All the members of the stroke units are acknowledged for their support in the study.
Code Availability
Not applicable.
Funding
This work was supported by “Project 355/C/2017, Fundació La Marató de TV3 in Strokes and traumatic spinal cord and brain injury, 2017 call of projects.”
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Ethics Approval
The study was approved by the Ethical Committee in line with the last Helsinki guidelines.
Consent to Participate
Written informed consent was obtained from all the participants.
Consent for Publication
The authors seek consent from individuals to publish their codified data.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pagola, J., Juega, J., Dorado, L. et al. Platelet Analysis in the Thrombus Plus Serum BNP for Detecting Clot-Related Atrial Fibrillation. Results From the ITACAT Multicentric Registry. Transl. Stroke Res. (2023). https://doi.org/10.1007/s12975-023-01220-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12975-023-01220-x